BSE Code - 500087
Face Value - Rs 2.00
Group - BSE 'A'
Shareholding pattern - (a)Promoters - 36.80%
(b)Institutions - 35.86%
(c)Non-Institutions - 26.23%
One year High-Low - Rs 575.20 - Rs 366.70
Cipla’s wholly owned subsidiary - Medispray Laboratories, has received an approval for acquisition of two manufacturing undertakings. A significant portion of the capacities of the two undertakings are dedicated for the manufacture of Cipla’s products. The acquisition of the aforesaid undertakings is expected to yield operational synergies. The board of directors at their meeting held on September 05, 2014 has approved for the same.
The consideration for the above two transactions are Rs 29 crore and Rs 71.93 crore respectively. The first manufacturing facility located at Goa is owned by Okasa and the second manufacturing facility located at Satara (Maharashtra) is owned by Okasa Pharma, the entities controlled by relatives of the promoters hold majority interest in the companies which own the aforesaid undertakings.
Current price of stock is Rs 563.10, up by 5.80 points from its previous closing of Rs 557.30 on the BSE.
No comments:
Post a Comment